|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 14/715 | |
| C07K 19/00 | |||
| A61K 38/19 | |||
| A61K 38/17 | |||
| A61K 39/395 | |||
| A61K 38/20 | |||
| A61P 37/00 | |||
| A61P 43/00 | |||
| A61K 38/00 |
| (11) | Patento numeris | 1173484 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 00928591.7 |
| Europos patento paraiškos padavimo data | 2000-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2002-01-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-07-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2000/011612 |
| Data | 2000-04-28 |
| (87) | Numeris | WO 2000/064944 |
| Data | 2000-11-02 |
| (30) | Numeris | Data | Šalis |
| 301808 | 1999-04-28 | US |
| (72) |
WYNN, Thomas, A., US
CHIARAMONTE, Monica, G., US
COLLINS, Mary, US
DONALDSON, Debra, US
FITZ, Lori, US
NEBEN, Tamlyn, US
WHITTERS, Matthew, J., US
WOOD, Clive, US
|
| (73) |
Genetics Institute, LLC,
87 Cambridge Park Drive, Cambridge, MA 02140,
US
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804, US |
| (54) | TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 AND IL-13 RECEPTOR CHAINS |
| TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 AND IL-13 RECEPTOR CHAINS |